Rocket Pharmaceuticals, Inc. (RCKT) investors who incurred losses advised to take action before deadline

Investors who have suffered losses as a result of investing in Rocket Pharmaceuticals, Inc. (RCKT) are encouraged to get in touch with Glancy Prongay & Murray LLP regarding securities fraud. The law firm is investigating potential claims on behalf of those who bought shares of Rocket stock between March 14, 2018, and September 25, 2020.

During this period, Rocket Pharmaceuticals made several positive statements about the efficacy and success of its lead gene therapy program. The company claimed that initial patient dosing in the Phase 1 clinical trial of its Fanconi anemia program was successful. However, on September 25, 2020, Rocket disclosed that there were inconsistencies in some of the preclinical study data for this program. This information led to significant declines in the price of Rocket stock, causing harm to investors who had purchased shares based on the company’s earlier positive statements.

Detective Joseph said that the company investors alerted them to investigate the matter sooner rather than later. they would be remiss to not take action on behalf of investors who have suffered losses due to potential securities fraud involving Rocket Pharmaceuticals.

If you invested in Rocket Pharmaceuticals, Inc. (RCKT) between March 14, 2018, and September 25, 2020, and experienced financial losses, you may be eligible to recover your losses. Investors interested in learning more about this investigation and potential legal claims should contact Glancy Prongay & Murray LLP.

The Law provides confidential consultations for those who have lost money due to securities fraud. The firm has represented individual and institutional investors in securities litigation for over 20 years, and recovers judgments in favor of its clients. Their goal is to hold those accountable for deceiving investors so that securities markets remain transparent and fair to all participants.

Investors who have suffered financial losses due to investing in Rocket Pharmaceuticals, Inc. (RCKT) are encouraged to contact Glancy Prongay & Murray LLP to learn more about their legal rights and potential options for recovery. It is essential to take action promptly if you believe you have been a victim of securities fraud to protect your interests and seek the compensation you may be entitled to under the law.